Equity research

Equity analysts covering Ascelia Pharma are found below:

Danske Bank
Lars Hevreng
+46 8 568 80568
lhev@danskebank.com

Vator Securities
Felicia Rittemar
+46 76014 45 55
felicia@vatorsec.se

Redeye
Ludvig Svensson
+46 704 96 25 35
ludvig.svensson@redeye.se

Analysguiden/Aktiespararna
Sten Westerberg
sten.westerberg@aktiespararna.se

 

Below you find recent equity research on Ascelia Pharma:

200526 – Analysguiden (in Swedish)

200325 – Equity Research Redeye (in Swedish)

200305 – Analysguiden-Carlsquare (in Swedish)

200220 – Equity Research Vator Securities

200220 – Analysguiden-Carlsquare (in Swedish)

191014 – Equity Research Redeye (in Swedish)

190619 – Swedish Shareholders Association Equity Research Analysguiden (in Swedish)

190528 – Swedish Shareholders Association Equity Research Analysguiden (in Swedish)

190521 – Equity Research Edison Group

190425 – Equity Research Vator Securities